R. Jiang

Post hoc analysis of two clinical trials to compare the immunogenicity and safety of different polio immunization schedules in Chinese infants

Changgui Li, T. Zhao, Hongyuan Shi, 2021, Annals of translational medicine.

Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population.

Changgui Li, Haitao Yang, Jian-feng Wang, 2021, Vaccine.

Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques

Wei Yang, H. Yang, Changgui Li, 2021, Molecular Therapy - Methods & Clinical Development.

An in-depth investigation of the safety and immunogenicity of an inactivated SARS-CoV-2 vaccine

Yang Gao, H. Yang, Y. Li, 2020, medRxiv.

Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults

W. Chen, Hongling Zhao, Changgui Li, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Innovative Vaccines in China

Ling Liu, Yan Li, Q. Xiao, 2019, Immunization Program in China.

[Epidemiological characteristics of mumps in mainland China from 2004 to 2018 and key population for prevention and control].

Yan Deng, Zhimei Zhao, Q. Yin, 2019, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

Effectiveness and safety of an inactivated enterovirus 71 vaccine in children aged 6-71 months in a phase IV study.

X. Guan, Y. Tong, Yang Wu, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18–59 years: A phase I randomized, double-blinded, controlled trial

Shan Lu, Changgui Li, Xuanyi Wang, 2021, Vaccine.

A valid protective immune response elicited in rhesus macaques by an inactivated vaccine is capable of defending against SARS-CoV-2 infection

Wei Yang, H. Yang, Changgui Li, 2020, bioRxiv.